STAT3 and Insulin resistance: Risperidone could reduce both leptin-induced signal transducer and activator of transcription 3 (STAT3) phosphorylation and insulin-mediated protein kinase B activation, which could result in LEP and insulin resistance (Piao et al., 2014).